Lactoferricin Dosing & Reconstitution Guide

Lactoferricin is a research peptide derived from bovine lactoferrin, and as such, specific dosing regimens are not applicable in the same manner as pharmaceutical compounds. In vitro studies have utilized Lactoferricin at concentrations ranging from 1 to 200 mcg/mL, illustrating its potential efficacy in various experimental settings. The variability in effective concentrations suggests that researchers should carefully consider their specific experimental designs and objectives when determining the appropriate concentration for their studies. Additionally, it is important to note that the route of administration is not applicable for this food-derived peptide, as it is primarily used in controlled laboratory environments.

Currently, there are no published human clinical trials assessing the safety and efficacy of Lactoferricin. As a peptide that emerges from the digestion of lactoferrin, it may elicit allergic reactions in individuals with a known cow milk protein allergy. This potential for hypersensitivity underscores the importance of caution in any research involving this compound. Furthermore, there is a lack of safety data regarding the use of Lactoferricin during pregnancy and breastfeeding, which necessitates a conservative approach. It is essential to emphasize that Lactoferricin is intended solely for research purposes and should not be considered for therapeutic use, given the absence of regulatory approval and established safety profiles.